TECH

Bio-Techne Corp. · XNAS · 131 sessions on record

Health Care

$72.47▲ +0.09 · +0.1%from $72.38 the session before · Sep 30, 2026 close · end of day

Open: $72.38
High: $72.55
Low: $72.33
Day's range: $0.220.30% of the previous close
VWAP: $72.46close +0.01% from it
Volume, shares: 3.14M1.02× the 20-session average
Traded, $: $227.4M
Trades: 20.6K150 shares per trade
Previous close: $72.38+0.09 to the close
Market cap: $11.36Bat the close of Sep 30

Day range64% of the way up

$72.33$72.55

52-week range99% of the way up

$43.20 May 15$72.69 Sep 22

−0.30% from the high · +68% from the low

Options

No listed options on TECH

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

131 sessions on file · from Mar 25

TECH close
S&P 500, rebased

Session read · latest close: Sep 30, 2026
Close $ · day %: $72.47▲ +0.1% on the previous close
Against S&P 500: S&P 500 −0.2%+0.3 pp difference on the day
Against the averages: above 20 · above 5020-session $72.39 (+0.11%) · 50-session $72.25 (+0.31%)
Volume: 1.02×the previous 20 sessions · 3.14M shares
Extremes on the day: none

Quarterly results

consolidated · latest filed Aug 24, 2026 · SEC filings

Revenue $321.2M, +1.3% on a year earlier in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session

Quarterly results of TECH on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue $	Revenue YoY	Profit $	Profit YoY	EPS $	Market on the day
Jun 2026filed Aug 24	$321.2M	▲ +1.3%	—	—	0.36	▼ −0.1%S&P 500 +0.3% · −0.4 pp
Mar 2026filed May 6	$311.4M	▼ −1.5%	$51.0M	▲ +130%	0.32	▲ +7.4%S&P 500 −0.3% · +7.7 pp
Dec 2025filed Feb 4	$295.9M	▼ −0.39%	$38.0M	▲ +8.9%	0.24	—not reached
Sep 2025filed Nov 5	$286.6M	▼ −1.0%	$38.2M	▲ +14%	0.24	—not reached
Jun 2025filed Aug 22	$317.0M	▲ +3.5%	−$17.7M	▼ −140%	-0.11	—not reached
Mar 2025filed May 6	$316.2M	▲ +4.2%	$22.6M	▼ −54%	0.14	▲ +7.4%S&P 500 −0.3% · +7.7 pp
Dec 2024filed Feb 4	$297.0M	▲ +9.0%	$34.9M	▲ +27%	0.22	—not reached
Sep 2024filed Nov 5	$289.5M	▲ +4.5%	$33.6M	▼ −34%	0.21	—not reached

By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends

Financial-year results of TECH on the consolidated basis, summed from the quarters filed
Year	Revenue $	Revenue YoY	Profit $	Profit YoY	EPS $
FY26to Jun 2026	$1.22B	▼ −0.38%	—	—	1.16
FY25to Jun 2025	$1.22B	▲ +5.2%	$73.4M	▼ −56%	0.46
FY24to Jun 2024	$1.16B	▲ +2.0%	$168.1M	▼ −41%	1.05
FY23to Jun 2023	$1.14B	▲ +2.8%	$285.3M	▲ +4.9%	1.76
FY22to Jun 2022	$1.11B	▲ +19%	$272.1M	▲ +94%	1.66

Fundamentals

consolidated · filings to Jun 2026 · close $72.47 on Sep 30

TECH trades at 62 times trailing earnings, 5.4 times book value, revenue −0.38% over twelve months, a 0.22% dividend yield, market cap $11.36B.

Valuation

Market cap: $11.36Bon Sep 30
Price to earnings: 62consolidated · four quarters to Jun 2026
Trailing EPS: $1.16diluted · consolidated · four quarters to Jun 2026
Price to book: 5.4consolidated · balance sheet to Jun 2026
Book value a share: $13.44consolidated · balance sheet to Jun 2026
Debt to equity: —
Return on equity: —
Dividend yield: 0.22%$0.16 a share in 365 days
Price to sales: 9.4market cap over revenue, four quarters to Jun 2026
Shares outstanding: 157Mon Sep 30

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: $1.22Bfour quarters to Jun 2026
Revenue growth, 12 months: ▼ −0.38%against the twelve months before
Revenue 3-year CAGR: ▲ +2.3%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months: —
Profit growth, 12 months: —
Profit 3-year CAGR: —

PeersBiological Products, (No Diagnostic Substances) · the ten largest by market cap · industry P/E needs two stocks with trailing profit and a market cap

Stocks in the industry Biological Products, (No Diagnostic Substances) with market cap, price to earnings and price to book
Stock	Market cap	P/E	P/B	Close $
MRNAModerna, Inc. Common Stock	$76.88Bon Sep 30	—	11	$192.57
HALOHalozyme Therapeutics, Inc.	$12.53Bon Sep 30	32consolidated	87	$110.40
TECHBio-Techne Corp.	$11.36Bon Sep 30	62consolidated	5.4	$72.47
KODKodiak Sciences Inc Common Stock	$5.96Bon Sep 30	—	98	$94.80
ALLOAllogene Therapeutics, Inc. Common Stock	$552.8Mon Sep 30	—	1.3	$1.60
DTILPrecision BioSciences, Inc. Common Stock	$172.8Mon Sep 30	—	3.8	$6.26
OTLKOutlook Therapeutics, Inc. Common Stock	$139.6Mon Sep 30	—	—	$0.57
BSEMBioStem Technologies, Inc. Common Stock	$55.2Mon Sep 30	—	2.0	$3.09
TVGNTevogen Inc. Common Stock	$43.1Mon Sep 30	—	—	$6.62
BCDABioCardia, Inc. Common Stock	$15.3Mon Sep 30	—	5.7	$1.01

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 220% of shares, BlackRock, Inc. the largest at 18%, FMR LLC 16% and VANGUARD CAPITAL MANAGEMENT LLC 13%, as filed for the quarter to Jun 2026.

17.9%16.3%13.0%173.9%

Held by 13F managers: 220%of shares outstanding
Shares held: 347M−9.6% on Mar 2026 among managers filing both
Managers holding: 555544 a quarter earlier
Largest holder: 18%BlackRock, Inc.

Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter

Largest 13F holders of TECH
Manager	Shares	Of outstanding	Value	Change on quarter
BlackRock, Inc.	28.1M	18%	$1.98B	+3.52M
FMR LLC	25.6M	16%	$1.81B	+9.79M
VANGUARD CAPITAL MANAGEMENT LLC	20.4M	13%	$1.44B	+77.7K
GOLDMAN SACHS GROUP INC	14.7M	9.4%	$1.04B	+10.8M
HBK INVESTMENTS L P	13.7M	8.7%	$964.4M	—
VANGUARD PORTFOLIO MANAGEMENT LLC	13M	8.3%	$919.3M	+52K
MORGAN STANLEY	12.7M	8.1%	$900.7M	−4.32M
STATE STREET CORP	12M	7.6%	$845.0M	+224K
GEODE CAPITAL MANAGEMENT, LLC	10.7M	6.8%	$755.1M	+478K
Invesco Ltd.	9.97M	6.4%	$704.6M	+795K

Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

TECH insider trades
Insider	Trade	Shares	Price	Held after
Crouse Steven C.Officer	exercised · Jun 2, 2026	600	—	6,977
Crouse Steven C.Officer	withheld for tax · Jun 2, 2026	216	$49.77	6,761
Herr Amy E.Director	exercised · May 8, 2026	6,636	$47.60	6,836
Herr Amy E.Director	sold · May 8, 2026	6,636	$48.28	200
Kelderman KimDirector,Officer	withheld for tax · May 5, 2026	23,951	$56.68	65,799
Kelderman KimDirector,Officer	exercised · May 5, 2026	26,692	$47.60	89,750
Bohnen ShaneOfficer	exercised · May 5, 2026	8,400	$47.60	14,304
Bohnen ShaneOfficer	withheld for tax · May 5, 2026	7,055	$56.68	7,249
Hippel JamesOfficer	exercised · May 5, 2026	62,000	$47.60	210,625
Hippel JamesOfficer	withheld for tax · May 5, 2026	56,955	$56.68	153,670

Corporate actions

exchange records

Nothing upcoming on record; the last was a dividend of $0.08 a share, ex-date Aug 24, 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in dollars a share, splits as ratios

Corporate actions of TECH, upcoming first, then the most recent
Ex-date	Action	Amount or ratio	Record date
recent
Aug 24, 2026	dividend	$0.08	—
May 18, 2026	dividend	$0.08	—

Calendardividends by ex-date

Dividends in 365 days: $0.16a share · ex-dates inside the year
Last dividend: $0.08ex-date Aug 24, 2026

Price history

131 sessions on record · to Sep 30 · end of day

TECH is +0.4% over 20 sessions against the S&P 500's +0.1%, 0.30% below its 52-week high, realised volatility 2.1% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions

Returns of the stock and S&P 500 over six windows, longest first
Window	From $	TECH %	S&P 500 %	Difference pp
120 sessionssince Apr 9	$55.57	▲ +30%	▲ +12%	+18
60 sessionssince Jul 7	$70.61	▲ +2.6%	▲ +2.0%	+0.63
20 sessionssince Sep 1	$72.18	▲ +0.40%	▲ +0.11%	+0.29
5 sessionssince Sep 23	$72.52	▼ −0.07%	▼ −0.67%	+0.60
1 sessionsince Sep 29	$72.38	▲ +0.12%	▼ −0.21%	+0.33

Averages of the closeclose against each average

5-session average: $72.51close −0.06% from it
20-session average: $72.39close +0.11% from it
50-session average: $72.25close +0.30% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: $0.180.25% of the close
Average day's range, 20: $0.170.23% of the close
Volume against 20 sessions: 1.02×3.14M vs 3.1M average

Volatility and co-movement with S&P 500annualised from daily returns

Realised volatility, 20: 2.1%≈ ±0.13% a session · moved more than that on 8 of 20
Realised volatility, 60: 3.6%≈ ±0.22% a session · moved more than that on 15 of 60
Beta to S&P 500, 60: 0.06moved with S&P 500 on 40 of 60 sessions

Up and down sessionscloses above and below the previous close

Last 20 sessions: 11 up · 9 downof 20
Last 60 sessions: 32 up · 27 downof 59
Best session, 250: ▲ +20%Jun 25
Worst session, 250: ▼ −16%May 6

Bio-Techne Corp. is held by

1 headlines on TECH

latest Sep 30, 2026 · links go to the publisher

Sep 30INCY or TECH: Which Is the Better Value Stock Right Now?Zacks Investment Research

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 47% of reported volume on Sep 30, 2026, against 33% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume

TECH daily short-sale volume
Session	Short volume	Reported volume	Short share
Sep 30, 2026	285K	604K	47.2%
Sep 29, 2026	325K	931K	34.9%
Sep 28, 2026	156K	1.24M	12.6%
Sep 25, 2026	154K	588K	26.3%
Sep 24, 2026	89.3K	844K	10.6%
Sep 23, 2026	324K	1.51M	21.5%
Sep 22, 2026	170K	1.36M	12.5%
Sep 21, 2026	125K	1.29M	9.7%
Sep 18, 2026	629K	1.21M	52.1%
Sep 17, 2026	200K	1.87M	10.7%

Filings

SEC EDGAR · newest first

TECH SEC filings
Filed	Form	Report date
Sep 30, 2026	4	Sep 28, 2026
Sep 24, 2026	4	Sep 22, 2026
Sep 23, 2026	8-K	Sep 23, 2026
Sep 14, 2026	DEFA14A	—
Sep 14, 2026	8-K	Sep 14, 2026
Sep 9, 2026	DEFA14A	—
Sep 2, 2026	DEFA14A	—
Aug 25, 2026	DEFA14A	—
Aug 24, 2026	10-K	Jun 30, 2026
Aug 20, 2026	DEFM14A	—
Aug 19, 2026	4	Aug 17, 2026
Aug 19, 2026	4	Aug 17, 2026
Aug 19, 2026	4	Aug 17, 2026
Aug 19, 2026	4	Aug 17, 2026
Aug 19, 2026	4	Aug 17, 2026
Aug 19, 2026	4	Aug 17, 2026
Aug 18, 2026	4	Aug 15, 2026
Aug 18, 2026	4	Aug 15, 2026
Aug 18, 2026	4	Aug 15, 2026
Aug 18, 2026	4	Aug 15, 2026
Aug 18, 2026	4	Aug 15, 2026
Aug 18, 2026	4	Aug 15, 2026
Aug 12, 2026	8-K	Aug 12, 2026
Aug 10, 2026	PREM14A	Aug 10, 2026
Aug 6, 2026	SCHEDULE 13G/A	—

About Bio-Techne Corp.

SEC and exchange records

Company: Bio-Techne Corp.
Exchange: XNAS
Industry: Biological Products, (No Diagnostic Substances) · SEC standard industrial classification
SEC CIK: 842023
Sessions on record: 131
Price source: End of day · delayed
Computed: 1 Oct, 08:01 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.